rs34637004

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_198173.3(GRHL3):​c.479T>C​(p.Val160Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0392 in 1,614,096 control chromosomes in the GnomAD database, including 1,490 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V160G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.034 ( 119 hom., cov: 32)
Exomes 𝑓: 0.040 ( 1371 hom. )

Consequence

GRHL3
NM_198173.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.288

Publications

13 publications found
Variant links:
Genes affected
GRHL3 (HGNC:25839): (grainyhead like transcription factor 3) This gene encodes a member of the grainyhead family of transcription factors. The encoded protein may function as a transcription factor during development, and has been shown to stimulate migration of endothelial cells. Multiple transcript variants encoding distinct isoforms have been identified for this gene.[provided by RefSeq, Aug 2010]
GRHL3 Gene-Disease associations (from GenCC):
  • van der Woude syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • van der Woude syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0018627644).
BP6
Variant 1-24336694-T-C is Benign according to our data. Variant chr1-24336694-T-C is described in ClinVar as Benign. ClinVar VariationId is 465250.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0335 (5104/152286) while in subpopulation NFE AF = 0.0462 (3143/68016). AF 95% confidence interval is 0.0449. There are 119 homozygotes in GnomAd4. There are 2573 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 5104 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRHL3NM_198173.3 linkc.479T>C p.Val160Ala missense_variant Exon 4 of 16 ENST00000361548.9 NP_937816.1 Q8TE85-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRHL3ENST00000361548.9 linkc.479T>C p.Val160Ala missense_variant Exon 4 of 16 1 NM_198173.3 ENSP00000354943.5 Q8TE85-5

Frequencies

GnomAD3 genomes
AF:
0.0335
AC:
5101
AN:
152168
Hom.:
119
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00755
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.0286
Gnomad ASJ
AF:
0.0314
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0101
Gnomad FIN
AF:
0.0912
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0462
Gnomad OTH
AF:
0.0320
GnomAD2 exomes
AF:
0.0339
AC:
8531
AN:
251324
AF XY:
0.0339
show subpopulations
Gnomad AFR exome
AF:
0.00696
Gnomad AMR exome
AF:
0.0204
Gnomad ASJ exome
AF:
0.0388
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0790
Gnomad NFE exome
AF:
0.0446
Gnomad OTH exome
AF:
0.0373
GnomAD4 exome
AF:
0.0398
AC:
58159
AN:
1461810
Hom.:
1371
Cov.:
32
AF XY:
0.0391
AC XY:
28400
AN XY:
727212
show subpopulations
African (AFR)
AF:
0.00597
AC:
200
AN:
33480
American (AMR)
AF:
0.0212
AC:
949
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.0385
AC:
1007
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0106
AC:
910
AN:
86252
European-Finnish (FIN)
AF:
0.0841
AC:
4489
AN:
53394
Middle Eastern (MID)
AF:
0.0309
AC:
178
AN:
5768
European-Non Finnish (NFE)
AF:
0.0435
AC:
48322
AN:
1111976
Other (OTH)
AF:
0.0348
AC:
2103
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
3029
6058
9086
12115
15144
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1700
3400
5100
6800
8500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0335
AC:
5104
AN:
152286
Hom.:
119
Cov.:
32
AF XY:
0.0346
AC XY:
2573
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.00753
AC:
313
AN:
41570
American (AMR)
AF:
0.0286
AC:
437
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0314
AC:
109
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.0104
AC:
50
AN:
4824
European-Finnish (FIN)
AF:
0.0912
AC:
968
AN:
10612
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0462
AC:
3143
AN:
68016
Other (OTH)
AF:
0.0317
AC:
67
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
245
491
736
982
1227
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0385
Hom.:
309
Bravo
AF:
0.0280
TwinsUK
AF:
0.0499
AC:
185
ALSPAC
AF:
0.0480
AC:
185
ESP6500AA
AF:
0.00862
AC:
38
ESP6500EA
AF:
0.0450
AC:
387
ExAC
AF:
0.0327
AC:
3970
Asia WGS
AF:
0.00577
AC:
20
AN:
3478
EpiCase
AF:
0.0449
EpiControl
AF:
0.0439

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

GRHL3-related disorder Benign:1
Mar 20, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Van der Woude syndrome 2 Benign:1
Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.74
T
BayesDel_noAF
Benign
-0.80
CADD
Benign
16
DANN
Benign
0.82
DEOGEN2
Benign
0.070
.;T;.;.
Eigen
Benign
-0.45
Eigen_PC
Benign
-0.23
FATHMM_MKL
Benign
0.63
D
LIST_S2
Benign
0.56
T;T;T;T
MetaRNN
Benign
0.0019
T;T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-0.55
N;N;.;.
PhyloP100
0.29
PrimateAI
Benign
0.44
T
PROVEAN
Benign
0.70
N;N;N;N
REVEL
Benign
0.043
Sift
Benign
0.51
T;T;T;T
Sift4G
Benign
0.52
T;T;T;T
Polyphen
0.0
.;.;.;B
Vest4
0.21
MPC
0.44
ClinPred
0.0049
T
GERP RS
3.7
Varity_R
0.053
gMVP
0.22
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34637004; hg19: chr1-24663184; COSMIC: COSV108035897; COSMIC: COSV108035897; API